These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25612785)

  • 41. Efficacy of sildenafil in HIV-related pulmonary arterial hypertension.
    Pergola V; Caruso C; Gnarini R; Fazio S; Ferraro S
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 2():S136-7. PubMed ID: 25635750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serious adverse events during a 6-min walk test in patients with pulmonary hypertension.
    Morris NR; Seale H; Harris J; Hall K; Hopkins P; Kermeen F
    Eur Respir J; 2015 Apr; 45(4):1179-82. PubMed ID: 25614170
    [No Abstract]   [Full Text] [Related]  

  • 43. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.
    DeSouza SA; Preston IR
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):467-76. PubMed ID: 25797801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of right-ventricular dysfunction in pulmonary arterial hypertension following sildenafil therapy.
    Romano S; Chung J; Farzaneh-Far A
    Eur Heart J; 2015 Aug; 36(30):2018. PubMed ID: 25713316
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today?
    Medarov BI; Judson MA
    Respir Med; 2015 May; 109(5):557-64. PubMed ID: 25666253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term data from the Swiss pulmonary hypertension registry.
    Mueller-Mottet S; Stricker H; Domenighetti G; Azzola A; Geiser T; Schwerzmann M; Weilenmann D; Schoch O; Fellrath JM; Rochat T; Lador F; Beghetti M; Nicod L; Aubert JD; Popov V; Speich R; Keusch S; Hasler E; Huber LC; Grendelmeier P; Tamm M; Ulrich S
    Respiration; 2015; 89(2):127-40. PubMed ID: 25661477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Postpartum pulmonary hypertension].
    Escalante JP; Diez A; Figueroa Casas M; Lasave A; Cursack G; Poy C; Rodríguez MS; Galuppo M; Zapata G
    Medicina (B Aires); 2015; 75(1):44-7. PubMed ID: 25637900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Raynaud's phenomenon with botulinum toxin type A.
    Zhang X; Hu Y; Nie Z; Song Y; Pan Y; Liu Y; Jin L
    Neurol Sci; 2015 Jul; 36(7):1225-31. PubMed ID: 25616446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension.
    Motoji Y; Tanaka H; Fukuda Y; Sano H; Ryo K; Imanishi J; Miyoshi T; Sawa T; Mochizuki Y; Matsumoto K; Emoto N; Hirata K
    Int J Cardiovasc Imaging; 2015 Apr; 31(4):691-8. PubMed ID: 25614330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approach to Optimize Pharmacological Treatment in Children.
    Olguín HJ
    Dose Response; 2019; 17(3):1559325819863986. PubMed ID: 31384240
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of pediatric pulmonary arterial hypertension: A focus on the NO-sGC-cGMP pathway.
    Beghetti M; Gorenflo M; Ivy DD; Moledina S; Bonnet D
    Pediatr Pulmonol; 2019 Oct; 54(10):1516-1526. PubMed ID: 31313530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension.
    Beghetti M; Rudzinski A; Zhang M
    BMC Cardiovasc Disord; 2017 Jul; 17(1):177. PubMed ID: 28676038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
    Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
    Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.
    Magee AG; Makhecha S; Bentley S
    Expert Opin Drug Saf; 2015 May; 14(5):633-42. PubMed ID: 25746065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of pulmonary arterial hypertension using extemporaneous formulation of sildenafil in Mexican children.
    Juárez Olguín H; Camacho Reyes L; Roldan Arce A; Calderón Guzmán D
    Pediatr Cardiol; 2015 Jun; 36(5):1019-23. PubMed ID: 25612785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of sildenafil in children with pulmonary arterial hypertension.
    Olguín HJ; Martínez HO; Pérez CF; Mendiola BR; Espinosa LR; Pacheco JLC; Pérez JF; Magaña IM
    World J Pediatr; 2017 Dec; 13(6):588-592. PubMed ID: 28791664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sildenafil in pediatric pulmonary arterial hypertension.
    Dhariwal AK; Bavdekar SB
    J Postgrad Med; 2015; 61(3):181-92. PubMed ID: 26119438
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.